SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-007301 to MedAvail Holdings, Inc. (MDVLQ) (CIK 0001402479)

MedAvail Holdings, Inc. (MDVLQ) (CIK 0001402479)
Date: July 10, 2023 · CIK: 0001402479 · Accession: 0000000000-23-007301

Regulatory Compliance Offering / Registration Process Financial Reporting

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-273032

Date
July 10, 2023
Author
Mark Doerr
Form
UPLOAD
Company
MedAvail Holdings, Inc. (MDVLQ) (CIK 0001402479)

Letter

United States securities and exchange commission logo July 10, 2023 Mark Doerr Chief Executive Officer MedAvail Holdings, Inc. 4720 East Cotton Gin Loop, Suite 220 Phoenix, AZ 85040 Re:MedAvail Holdings, Inc. Registration Statement on Form S-3 Filed June 29, 2023 File No. 333-273032 Dear Mark Doerr: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Kate Beukenkamp at 202-551-3861 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc: John McIlvery

Show Raw Text
United States securities and exchange commission logo
July 10, 2023
Mark Doerr
Chief Executive Officer
MedAvail Holdings, Inc.
4720 East Cotton Gin Loop, Suite 220
Phoenix, AZ 85040
Re:MedAvail Holdings, Inc.
Registration Statement on Form S-3
Filed June 29, 2023
File No. 333-273032
Dear Mark Doerr:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Kate Beukenkamp at 202-551-3861 with any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc:       John McIlvery